tiprankstipranks
Trending News
More News >

PFI Advances New Autoimmune Disease Antibody

PFI Advances New Autoimmune Disease Antibody

Pharma Foods International Co., Ltd. (JP:2929) has released an update.

Confident Investing Starts Here:

Pharma Foods International Co., Ltd. (PFI) has reached a significant milestone under its Exclusive Licensing Agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) for a new antibody aimed at treating autoimmune diseases. The antibody, developed using PFI’s proprietary ALAgene® technology, is set to enter Phase I clinical trials following the acceptance of an initial Clinical Trial Notification. PFI’s achievement paves the way for a milestone payment and reinforces its commitment to addressing unmet medical needs.

For further insights into JP:2929 stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App